Home · Healthcare M&A · Sell an Article 31 MHOTRS Clinic in NY

NY Article 31 MHOTRS · Active Buyer Mandates

Sell an Article 31 MHOTRS Clinic in NY

Nexus Bridge represents owners of NY OMH-licensed Article 31 Mental Health Outpatient Treatment and Rehabilitative Services (MHOTRS) programs across the five boroughs, Long Island, Westchester, and the Hudson Valley. The behavioral health M&A market is one of the most active in 2026 — we currently have multiple active PE and strategic buy-side mandates for MHOTRS programs. The Article 31 license is a scarce, durable asset that PE platforms pay a meaningful premium for. $0 upfront. Success-only commission.

2026 MHOTRS market signal: Behavioral health is one of the most actively consolidated healthcare segments in NY/NJ/CT. PE platforms paying premium multiples (6×–10× EBITDA) for multi-site MHOTRS programs with clinician retention, Medicaid Managed Care diversity, and clean OMH compliance history. New Article 31 licenses require OMH Prior Approval Review — existing license holders sit on a regulatory moat buyers pay for.

What MHOTRS actually is in 2026

In 2023 NY OMH consolidated five legacy outpatient mental health regulations (Parts 587, 588, 599, 596, 595) into a single new framework: 14 NYCRR Part 599 — Mental Health Outpatient Treatment and Rehabilitative Services (MHOTRS). This was a regulatory restructuring, not a license elimination — every Article 31 outpatient mental health clinic operating in NY today is operating under the MHOTRS framework. The term "Article 31 clinic" and "MHOTRS clinic" refer to the same thing in current practice.

MHOTRS programs provide a defined set of outpatient mental health services: comprehensive diagnostic evaluation, individual psychotherapy, group psychotherapy, family therapy, medication management, crisis intervention, care coordination and case management, peer support services, and rehabilitation services. Service delivery is by licensed mental health professionals — licensed clinical social workers (LCSWs), licensed master social workers (LMSWs), licensed mental health counselors (LMHCs), psychologists, psychiatrists, psychiatric nurse practitioners, and licensed marriage and family therapists (LMFTs). MHOTRS programs serve children, adolescents, adults, and seniors across the full range of severities — from mild adjustment disorders through serious mental illness with co-occurring substance use disorders.

Programs can be free-standing or hospital-based, full-service or specialty (e.g., child and adolescent only, geriatric only, eating disorders, co-occurring SUD). Telehealth is now a permanent component of MHOTRS service delivery under the post-pandemic OMH telehealth rules.

2026 MHOTRS valuation multiples

Behavioral health M&A has been one of the most active healthcare segments since 2019, accelerated by the post-COVID demand spike and structural mental-health-access shortfall. MHOTRS programs trade at premium multiples versus office-based mental health practices because of the license-protected revenue stream, Medicaid Managed Care contracting, and OMH regulatory moat.

MHOTRS ConfigurationEBITDA MultipleKey Driver
Single-site MHOTRS clinic ($500K–$1M EBITDA)4×–6×Scale below platform-eligible; clinician retention risk weights down
Multi-site MHOTRS (2–4 clinics, $1M–$2M EBITDA)6×–8×Regional density and infrastructure scale
Multi-site MHOTRS (5+ clinics, $2M+ EBITDA)7×–10×PE platform-eligible; full diligence pricing range
Article 28 + Article 31 combined site7×–10×Collaborative Care primary-care + behavioral-health integration premium
Child & adolescent specialty MHOTRS6×–9×Pediatric specialty premium; durable referral patterns
Co-occurring SUD specialty MHOTRS6×–9×Cross-licensed Article 31 + OASAS; broader buyer universe
Geriatric MHOTRS5×–8×Medicare Advantage growth tailwind
Telemedicine-only MHOTRS5×–8×CMS site-of-service rule risk caps upper range
Hospital-affiliated MHOTRSvariesSponsoring hospital typically retains right of first refusal

Multiples assume trailing-12 normalized EBITDA, OMH compliance history clean of consent orders, clinician retention plan documented, no material payer concentration, lease term >5 years remaining. License-quality premium typically 1.0×–1.5× EBITDA above a comparable office-based mental health practice. Deduct 0.5×–1.5× for OMH corrective action history, >30% single-payer concentration, short lease, or undocumented clinician retention exposure.

The OMH approval process — faster than Article 28

Article 31 MHOTRS transactions move materially faster than Article 28 D&TC transactions because OMH approval is faster than PHHPC CON. Any 10%+ ownership change requires OMH Prior Approval Review (PAR) and an updated operating certificate. OMH reviews typically run 4–9 months — versus 6–14 months for PHHPC.

What OMH reviews in a PAR

What OMH does NOT require

Unlike Article 28 PHHPC, OMH PAR review does not typically include a community-need analysis. Continuation transactions where services and catchment remain the same usually receive PAR approval without need-based scrutiny. This is the primary reason MHOTRS transactions move 30–40% faster than Article 28 D&TC transactions.

Two-step close is optional, not mandatory

Because OMH approval is faster than PHHPC, MHOTRS transactions don't always require the two-step close structure that Article 28 deals do. Three common structures:

  1. Single-close (asset deal with management transition): Single close at month 6–9. Buyer takes economic and operational control simultaneously upon OMH approval. Most common for single-site and small multi-site MHOTRS programs.
  2. Two-step close (MSO-first, license-transfer second): Initial close on management services entity and real estate at month 4–5; deferred close on the license-holder entity at month 7–10 contingent on OMH approval. Used for larger PE platform deals where the buyer wants economic flow earlier.
  3. Management agreement with deferred purchase option: Used when OMH approval timing is uncertain. Buyer operates the program under a management services agreement; purchase right exercises upon OMH approval. Less common in 2026 but seen in distressed scenarios.
Choosing the right close structure for your MHOTRS sale depends on OMH posture toward the specific buyer, payer mix complexity, and the size of the transaction. Experienced healthcare M&A counsel is essential — structures that work for Article 28 D&TCs do not always optimize for MHOTRS deals.

Active PE buyers for NY MHOTRS programs

Behavioral health is one of the most active PE-investing healthcare segments in 2026 — partly driven by structural mental-health-access shortfall, partly by the post-COVID demand spike that hasn't subsided. The active buy-side universe for MHOTRS programs:

LifeStance Health (NASDAQ: LFST)

Largest U.S. outpatient mental health platform — 7,000+ clinicians, 500+ practices across 33 states. TPG and Summit Partners were original PE sponsors; now publicly traded. Active NY/NJ acquirer; productivity-pressure clinical model is well-documented. Best-fit acquirer for sellers prioritizing cash-at-close over clinical-autonomy preservation.

Refresh Mental Health / Lifepoint Behavioral Health

One of the most active behavioral health PE platforms in 2024–2026. PE-backed (recapitalization by Lifepoint Health / Apollo Global Management). Multi-site outpatient mental health focus including MHOTRS programs. Generally regarded as preserving clinical autonomy more than LifeStance.

Mindpath Health

Kohlberg & Company-backed. ~600 clinicians across multiple states. Active East Coast acquirer; targets multi-site MHOTRS-eligible programs.

Discovery Behavioral Health

Webster Equity Partners-backed. Eating disorders, child/adolescent mental health, substance use specialty platform. Acquires specialty MHOTRS programs aligned with verticals.

Eating Recovery Center / Pathlight Mood & Anxiety Center

CCMP Capital-backed. Eating disorders and mood/anxiety specialty platform. Selective MHOTRS-aligned acquisitions.

Embark Behavioral Health

Audax Group-backed. Adolescent mental health platform. Acquires teen-focused MHOTRS programs.

Acadia Healthcare (NASDAQ: ACHC)

Publicly traded. 250+ behavioral healthcare facilities (residential, partial hospitalization, intensive outpatient, outpatient). Active acquirer of multi-modality programs including MHOTRS-licensed outpatient components.

Universal Health Services (NYSE: UHS)

Publicly traded. Major behavioral health operator; selective MHOTRS acquisitions where they complement existing inpatient/PHP programs.

Strategic health system acquirers

Mount Sinai Behavioral Health, NYU Langone, Northwell Behavioral Health, Montefiore Behavioral Health Center, Maimonides Medical Center. Each runs an active behavioral health expansion strategy. Strategic acquirers typically value continuity and integration with broader system over PE-style multiple expansion — different deal economics but often better post-close cultural fit.

Smaller PE / regional MSO platforms

A growing tier of regional PE-backed MSO platforms specifically targets OMH-licensed Article 31 programs in NY/NJ metro. These platforms (typically $25M–$200M fund size, $1M–$10M deal range) offer the most active acquisition appetite for single-site and small multi-site MHOTRS sellers — the segment that the large national platforms skip.

Active Nexus Bridge buy-side mandates as of 2026-05-20: We currently represent buyers actively seeking Article 31 MHOTRS programs across the NY metro. Mandates updated monthly. If you own a MHOTRS program, we can tell you within 48 hours whether your specific profile matches an active mandate or whether we run a broader process.

Key value drivers for MHOTRS valuation

2026 MHOTRS deal structure norms

Deal Component2026 Norm
Cash-at-close65–80% for sub-platform deals; 55–75% for platform-deal rollover-heavy structures
Rollover equity10–30% (PE platforms strongly prefer rollover; strategic acquirers vary)
Earnouts10–25%; tied to 2–3 year EBITDA targets, caseload growth, or specific MMC plan retention
Seller post-close commitment2–5 year employment agreements (medical director or program director role); 3–5 years if <55 years old
Clinical staff retention bonuses$3K–$15K per LMSW/LCSW/LMHC; $15K–$50K per prescriber; typically 2-year vesting
Minimum staff signing requirement70–80% of FTE-equivalent clinicians signing offer letters before closing
Real estateLease assignment standard; sale-leaseback if owner-owned; cap rate 7–8%
Non-compete2–5 years; 5–15 mile radius; NY sale-of-business non-competes enforceable under BDO Seidman v. Hirshberg standard
Working capital pegCash-free / debt-free; MHOTRS-specific: A/R aging (60+ day discounted), MMC clean claims rate, denials/appeals backlog
Escrow / R&W holdback8–12% for 12–24 months. OMH-denial indemnification standard.
Quality of Earnings (QoE)Buyer-paid above $1.5M EBITDA. Sell-side QoE strongly recommended — PE diligence on MHOTRS is detailed.

The regulatory stack behind every MHOTRS sale

NY State

Federal

Commercial payer credentialing

Aetna, Cigna, UnitedHealthcare, Empire BCBS, EmblemHealth, MVP, Oxford. 60–180 days re-credentialing windows. Build credentialing-gap revenue escrow into deal structure.

Frequently asked questions

What is an Article 31 MHOTRS clinic?

Article 31 of NY Mental Hygiene Law governs outpatient mental health clinics licensed by the NY Office of Mental Health (OMH). In 2023 OMH consolidated five legacy clinic regulations into 14 NYCRR Part 599 — Mental Health Outpatient Treatment and Rehabilitative Services (MHOTRS). MHOTRS programs deliver outpatient psychiatric and psychotherapy services by licensed clinicians (LCSWs, LMSWs, LMHCs, psychologists, psychiatrists, psychiatric NPs, LMFTs) serving children through seniors.

What is the OMH approval process?

Any 10%+ ownership change requires OMH Prior Approval Review (PAR) and updated operating certificate. The buyer files an application covering ownership structure, financial capacity, character and competence, continuity of services, governing body, and QA program. OMH reviews typically run 4–9 months — meaningfully faster than the PHHPC CON process for Article 28 D&TCs.

What multiples do MHOTRS clinics sell for in 2026?

Single-site (under $1M EBITDA): 4×–6×. Multi-site (2–4 clinics, $1M–$2M EBITDA): 6×–8×. Multi-site (5+ clinics, $2M+ EBITDA): 7×–10× (PE platform-eligible). Article 28 + Article 31 integrated: 7×–10×. Specialty (child/adolescent, eating disorders, co-occurring SUD): 6×–9×. License premium typically 1.0×–1.5× EBITDA above comparable office-based mental health practice.

Who are the active PE buyers in 2026?

LifeStance Health, Refresh Mental Health / Lifepoint, Mindpath Health (Kohlberg), Discovery Behavioral Health (Webster Equity), Eating Recovery Center (CCMP), Embark (Audax), Acadia Healthcare, Universal Health Services, plus regional PE-backed MSO platforms targeting NY MHOTRS. Strategic acquirers: Mount Sinai, NYU Langone, Northwell, Montefiore, Maimonides. We currently have multiple active buy-side mandates.

How long does an Article 31 MHOTRS sale take?

8–14 months from engagement to funded close — meaningfully faster than Article 28 D&TC (12–18 months) because OMH approval is faster than PHHPC CON. Single-site asset transitions without 10%+ ownership change can close in 4–7 months. Multi-site PAR-reviewed transactions run 10–14 months. MMC plan transitions (60–180 days per plan) typically the rate-limiter post-OMH.

What is the MHOTRS rate code structure?

NY State Medicaid pays MHOTRS programs through 14 APG-based rate codes with carved-out higher rates for clinic services. Medicaid Managed Care plans typically pay at the state MHOTRS rate. 2024 OMH rate enhancements added meaningful capacity payments. The structured rate code system makes per-encounter revenue more predictable than fee-for-service mental health — which is why PE platforms pay a premium for license-protected MHOTRS revenue.

What is the clinician retention risk?

Clinician retention is the dominant deal-execution risk. Mental health clinician attrition runs 20–30% annually industry-wide. PE buyers require detailed retention plans, stay bonuses ($3K–$15K per LMSW/LCSW/LMHC, $15K–$50K per prescriber over 2 years), minimum-percentage closing conditions on clinical staff signing offer letters (70–80% of FTE-equivalent clinicians), and post-close compensation preservation. Buyers vary on clinical autonomy preservation — LifeStance is known for productivity-pressure; Refresh and several smaller PE platforms preserve clinical autonomy more.

Does Nexus Bridge charge upfront fees?

No. Success-only commission. 10% on first $1M, 8% on $1M–$5M, 6% on $5M–$10M, Lehman-formula scaling above $10M. OMH PAR preparation support, NY healthcare M&A counsel coordination, sell-side QoE, MMC transition planning, and clinician retention plan development included at no additional cost.

How a Nexus Bridge MHOTRS engagement runs

  1. Free 30-minute confidential conversation. Program profile, timeline, target valuation, OMH posture. $0, no obligation.
  2. Buy-side mandate match check. Within 48 hours we tell you whether your specific MHOTRS profile matches an active buy-side mandate we represent, or whether we run a broader process.
  3. Free evidence-based valuation. NY MHOTRS comparable transaction analysis with size and specialty-specific multiples. Delivered in writing within 7 days.
  4. Engagement letter. $0 upfront retainer, success-only commission. 12-month exclusivity, 12-month named-buyer tail.
  5. OMH compliance pre-screen. Part 599 documentation review, clinical record audit sample, QA program review, OMH inspection history review.
  6. Sell-side Quality of Earnings. Healthcare-experienced CPA firm coordinated to defend normalized EBITDA.
  7. Clinician retention plan. Detailed retention strategy: stay bonuses, post-close comp structure, key-prescriber retention, minimum-percentage closing condition feasibility.
  8. CIM preparation. Tailored to PE behavioral health buyer expectations: caseload trends, payer mix, MMC plan portfolio, prescriber FTE, EHR, telehealth integration, clinical leadership tenure.
  9. Targeted buyer outreach. Active mandate match plus broader market outreach to behavioral health PE platforms and strategic health-system acquirers.
  10. Multi-LOI negotiation. Comparison framework on cash split, rollover, earnout, employment, real estate, OMH risk allocation, clinical model preservation.
  11. OMH PAR workstream. Buyer-counsel-led but coordinated; we manage the seller side of PAR information requests, character-and-competence documentation, and continuity-of-services plan.
  12. Close coordination. Typically single-close at month 7–10 post-OMH approval; two-step close where economically beneficial.

Active buyer mandates right now

If you own an Article 31 MHOTRS program in NY and are considering a sale in the next 6–36 months, the behavioral health buyer demand is real and current. We currently represent multiple PE and strategic buyers actively seeking MHOTRS programs across the NY metro. Reach out and we'll tell you within 48 hours whether your specific profile matches an active mandate or whether we run a broader process.

Related: Healthcare M&A NJ Guide · Sell an Article 28 Clinic · Sell a Behavioral Health Practice (NJ) · Sell a Clinic (Multi-State) · Quality of Earnings Guide

Free & Confidential

Talk to a Buyer for Your MHOTRS Program

No obligation. No upfront fee. We reply within 1 business day with a buy-side mandate match assessment.

Fully confidential. We never contact your staff, patients, or referral sources without your permission.